138 related articles for article (PubMed ID: 11761434)
1. Thyrotropin-secreting pituitary adenomas. Clinical and biological heterogeneity and current treatment.
Sanno N; Teramoto A; Osamura RY
J Neurooncol; 2001 Sep; 54(2):179-86. PubMed ID: 11761434
[TBL] [Abstract][Full Text] [Related]
2. 2013 European thyroid association guidelines for the diagnosis and treatment of thyrotropin-secreting pituitary tumors.
Beck-Peccoz P; Lania A; Beckers A; Chatterjee K; Wemeau JL
Eur Thyroid J; 2013 Jun; 2(2):76-82. PubMed ID: 24783044
[TBL] [Abstract][Full Text] [Related]
3. Somatostatin Analogue Treatment of a TSH-Secreting Adenoma Presenting With Accelerated Bone Metabolism and a Pericardial Effusion: A Case Report.
Mousiolis AC; Rapti E; Grammatiki M; Yavropoulou M; Efstathiou M; Foroglou N; Daniilidis M; Kotsa K
Medicine (Baltimore); 2016 Jan; 95(2):e2358. PubMed ID: 26765410
[TBL] [Abstract][Full Text] [Related]
4. [Thyrotropin-secreting pituitary adenomas: clinical features and results of treatment in 45 patients].
Trukhina DA; Przhiyalkovskaya EG; Belaya ZE; Grigoriev AY; Azizyan VN; Mamedova EO; Rozhinskaya LY; Lapshina AM; Pigarova EA; Dzeranova LK; Platonova NM; Troshina EA; Melnichenko GA
Probl Endokrinol (Mosk); 2023 Sep; 70(2):23-36. PubMed ID: 38796758
[TBL] [Abstract][Full Text] [Related]
5. A reference center study in thyrotropin-secreting pituitary adenomas: clinicopathological, therapeutic and long-term follow-up outcomes.
Sözen M; Bayrak BY; Selek A; Şen HE; Çetinarslan B; Cantürk Z; Civriz AH; Balcı S; Gezer E; Köksalan D; Ceylan S
Endocrine; 2023 Dec; 82(3):622-630. PubMed ID: 37561380
[TBL] [Abstract][Full Text] [Related]
6. The biological behavior and clinical outcome of pituitary adenoma are affected by the microenvironment.
Li Y; Ren X; Gao W; Cai R; Wu J; Liu T; Chen X; Jiang D; Chen C; Cheng Q; Wu A; Cheng W
CNS Neurosci Ther; 2024 May; 30(5):e14729. PubMed ID: 38738958
[TBL] [Abstract][Full Text] [Related]
7. Regulation of long noncoding RNAs in the pathogenesis and clinical implications of pituitary adenomas.
Wang L; Xu D
Immun Inflamm Dis; 2023 Oct; 11(10):e1047. PubMed ID: 37904679
[TBL] [Abstract][Full Text] [Related]
8. Early identification of postoperative remission for thyrotropin-secreting adenomas.
Fan L; Wang Z; Sun W; Cui Q; Wu W; Xiang B; Ma Z; Wu Y; Wang Y; Zhang Z; Li Y; He M; Ye H
Clin Endocrinol (Oxf); 2024 May; ():. PubMed ID: 38818679
[TBL] [Abstract][Full Text] [Related]
9. Consensus guideline for the diagnosis and management of pituitary adenomas in childhood and adolescence: Part 1, general recommendations.
Korbonits M; Blair JC; Boguslawska A; Ayuk J; Davies JH; Druce MR; Evanson J; Flanagan D; Glynn N; Higham CE; Jacques TS; Sinha S; Simmons I; Thorp N; Swords FM; Storr HL; Spoudeas HA
Nat Rev Endocrinol; 2024 May; 20(5):278-289. PubMed ID: 38336897
[TBL] [Abstract][Full Text] [Related]
10. Pituitary adenomas: new insights, new therapeutic targets.
Tritos NA
Cell Res; 2023 Jan; 33(1):3-4. PubMed ID: 36588122
[No Abstract] [Full Text] [Related]
11. Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases.
Yamada S; Fukuhara N; Horiguchi K; Yamaguchi-Okada M; Nishioka H; Takeshita A; Takeuchi Y; Ito J; Inoshita N
J Neurosurg; 2014 Dec; 121(6):1462-73. PubMed ID: 25237847
[TBL] [Abstract][Full Text] [Related]
12. Coexistence of TSH-secreting adenoma and primary hypothyroidism: a case report and review of literature.
Ren X; Wang X; Chen G; Liu X; Guo H; Li M
BMC Endocr Disord; 2023 May; 23(1):116. PubMed ID: 37221515
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis and Treatment of Nonfunctioning Pituitary Adenomas with Thyroid Disorders.
Wang X; Li M; Liu X; Liang J; Guo H; Chen G
Int J Endocrinol; 2023; 2023():2846601. PubMed ID: 37020857
[TBL] [Abstract][Full Text] [Related]
14. Thyrotropin-secreting pituitary adenomas induce left atrial enlargement with subclinical atrial fibrillation: an echocardiographic study.
Yoshiki K; Sasagawa Y; Shimojima M; Takeshita Y; Takata S; Hayashi Y; Takamura T; Tachibana O; Nakada M
Pituitary; 2021 Oct; 24(5):778-786. PubMed ID: 34009499
[TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics and thyroid hormone dynamics of thyrotropin-secreting pituitary adenomas at a single institution.
Taguchi A; Kinoshita Y; Yamasaki F; Arita K; Tominaga A
Endocrine; 2021 Jul; 73(1):151-159. PubMed ID: 33283257
[TBL] [Abstract][Full Text] [Related]
16. Giant pituitary adenoma: histological types, clinical features and therapeutic approaches.
Iglesias P; Rodríguez Berrocal V; Díez JJ
Endocrine; 2018 Sep; 61(3):407-421. PubMed ID: 29909598
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis and treatment of TSH-secreting adenomas: review of a longtime experience in a reference center.
Nazato DM; Abucham J
J Endocrinol Invest; 2018 Apr; 41(4):447-454. PubMed ID: 29022276
[TBL] [Abstract][Full Text] [Related]
18. Short-term Preoperative Octreotide for Thyrotropin-secreting Pituitary Adenoma.
Fang HJ; Fu Y; Wu HW; Sun YL; Li YF; Zhang YZ; Zhong LY
Chin Med J (Engl); 2017 Apr; 130(8):936-942. PubMed ID: 28397723
[TBL] [Abstract][Full Text] [Related]
19. Thyrotropin-secreting pituitary adenomas: epidemiology, diagnosis, and management.
Amlashi FG; Tritos NA
Endocrine; 2016 Jun; 52(3):427-40. PubMed ID: 26792794
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
